Overview
The speaker discusses personal experiences and detailed insights regarding IGF-1 LR3—a peptide used in bodybuilding to enhance muscle growth—covering its mechanisms, comparisons with other substances, effective usage cycles, and side effects.
IGF-1 LR3 and Muscle Growth
- IGF-1 is a natural hormone responsible for muscle hyperplasia, hypertrophy, and new muscle tissue growth.
- Bodybuilders aim to spike IGF-1 levels via diet, growth hormone, insulin, MK677, and other supplements.
- IGF-1 LR3 and combinations of HGH with insulin most effectively increase IGF-1 levels.
- Regular IGF-1 affects many cell types, while IGF-1 LR3 is more potent in muscle cells, boosting protein synthesis and glucose uptake.
Experiences With HGH, Insulin, and Alternatives
- Using HGH and insulin led to rapid muscle growth but posed risks when proper nutrition wasn't maintained.
- Insulin misuse can cause dangerous hypoglycemia; speaker recounts personal incident requiring urgent sugar intake.
- Alternatives like MK677 and “Slim Pills” mimic insulin effects more safely by aiding carbohydrate conversion and lowering blood sugar, though less effectively than insulin.
Mechanism of IGF-1 LR3
- IGF-1 LR3 binds to IGF-1 and insulin receptors, activating pathways such as PI3K/AKT and mTOR, critical for muscle growth.
- mTOR is particularly important for initial muscle gains and can become less responsive with continuous training.
- For maximal effect, IGF-1 LR3 is often combined with testosterone and other anabolic agents.
Dosage and Cycle Recommendations
- IGF-1 LR3 cycles should last 2–4 weeks due to diminishing returns as the body adapts.
- Suggested protocol is four weeks on IGF-1 LR3, followed by four to eight weeks off.
- Optimal results require a well-structured diet and training during the cycle; best used toward the end of an anabolic cycle.
Side Effects and Personal Observations
- Reported side effects include muscle/joint pain and injection site irritation.
- Speaker experienced significant muscle pumps and mild, brief irritation at the injection site but no lasting pain.
- Emphasizes the importance of understanding risks, especially with insulin, and encourages cautious use only for research purposes.
Audience Engagement
- Speaker requests feedback on IGF-1 LR3 experiences and encourages viewers to check additional resources and subscribe to the channel.